Search

Your search keyword '"Sweis, Jaleel"' showing total 14 results
Start Over Author "Sweis, Jaleel"
14 results on '"Sweis, Jaleel"'

3. Vaccination in the Era of Immunosuppression

Author

Alnaimat, Fatima, primary, Sweis, Jaleel Jerry G., additional, Jansz, Jacqueline, additional, Modi, Zeel, additional, Prasad, Supritha, additional, AbuHelal, Ayman, additional, Vagts, Christen, additional, Hanson, Hali A., additional, Ascoli, Christian, additional, Novak, Richard M., additional, Papanikolaou, Ilias C., additional, Rubinstein, Israel, additional, and Sweiss, Nadera, additional

Published
2023
Full Text
View/download PDF

5. Predictors of glaucoma knowledge and its risk factors among Jordanian patients with primary open angle glaucoma at a tertiary teaching hospital: A cross-sectional survey

Author

Muhsen, Sana’, primary, Al-Huneidy, Leen, additional, Maaita, Ward, additional, AlQirem, Lina, additional, Madain, Zaid, additional, Sweis, Jaleel, additional, Abu Tawileh, Raya, additional, Al-Huneidy, Yazan, additional, Alkhatib, Amro, additional, and Al-Ani, Abdallah, additional

Published
2023
Full Text
View/download PDF

6. Immune-mediated lung diseases: A narrative review

Author

Sweis, Jaleel Jerry G., primary, Sweis, Nabil W. G., additional, Alnaimat, Fatima, additional, Jansz, Jacqueline, additional, Liao, Ting-Wei Ernie, additional, Alsakaty, Alaa, additional, Azam, Abeera, additional, Elmergawy, Hesham, additional, Hanson, Hali A., additional, Ascoli, Christian, additional, Rubinstein, Israel, additional, and Sweiss, Nadera, additional

Published
2023
Full Text
View/download PDF

8. Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant

Author

Sweiss, Karen, primary, Hofmeister, Craig C, additional, Quigley, John G., additional, Sweis, Jaleel G., additional, Kurzweil, Kaily, additional, Sborov, Douglas W., additional, Sharp, Lisa, additional, Calip, Gregory S, additional, Maahs, Lucas, additional, Avila, Ana Maria, additional, Uzoka, Chukwuemeka, additional, Ilo, Elizabeth, additional, Wolf, Elliot, additional, Rondelli, Damiano, additional, and Patel, Pritesh, additional

Published
2022
Full Text
View/download PDF

9. Pre-Transplant Assessment of Adult Sickle Cell Patients Shows a High Prevalence of Psychosocial Frailties before Allogeneic Stem Cell Transplant

Author

Sweiss, Karen, primary, Saraf, Santosh L., additional, Doane, Alison, additional, Mandava, Monika, additional, Sun, Ryan, additional, Khan, Mahir, additional, Hamilton, Zacharie Paul Charles, additional, Sweis, Jaleel G., additional, Gordeuk, Victor R., additional, Rondelli, Damiano, additional, Sharp, Lisa, additional, and Patel, Pritesh, additional

Published
2022
Full Text
View/download PDF

11. Cardiac Sarcoidosis with Peripheral Lymphopenia is Responsive to Adalimumab Therapy

Author

Sweis, Jaleel Jerry G., primary, Sweis, Nabil William G., additional, Ascoli, Christian, additional, Levin, Benjamin, additional, Avitall, Boaz, additional, Rubinstein, Israel, additional, Kondos, George, additional, Culver, Daniel A., additional, Judson, Marc, additional, Baughman, Robert, additional, Darbar, Dawood, additional, Drake, Wonder, additional, Shahrara, Shiva, additional, Sweiss, Nadera, additional, and Cooper, Leslie T., additional

Published
2022
Full Text
View/download PDF

12. Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review

Author

Sweis, Jaleel Jerry G., primary, Sweis, Nabil William G., additional, Ascoli, Christian, additional, Levin, Benjamin, additional, Avitall, Boaz, additional, Rubinstein, Israel, additional, Kondos, George, additional, Culver, Daniel A., additional, Judson, Marc, additional, Baughman, Robert, additional, Darbar, Dawood, additional, Drake, Wonder, additional, Shahrara, Shiva, additional, Cooper, Leslie T., additional, and Sweiss, Nadera J., additional

Published
2022
Full Text
View/download PDF

13. Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil.

Author

Chow KW, Sweis JJG, Alawneh D, Jetanalin P, Ascoli C, Kuschel S, Hoyer S, Braniecki M, and Sweiss N

Abstract

Bullous systemic lupus erythematosus (BSLE) is a rare autoimmune blistering disorder of cutaneous lupus erythematosus (CLE) that typically manifests as an acute vesiculobullous eruption in a patient with systemic lupus erythematosus (SLE). Also, it can rarely present as the initial clinical manifestation of SLE. There is no established US Food and Drug Administration (FDA) therapy for BSLE. We report a case of a 71-year-old Hispanic woman with SLE and lupus nephritis classes III and V who presented to the hospital with a worsening rash with painful, ruptured blisters involving the upper arms, chest, and back. Our patient did not respond to topical or systemic steroids but improved rapidly to combination therapy with intravenous immunoglobulin (IVIg) and mycophenolate mofetil (MMF)., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Chow et al.)

Published
2023
Full Text
View/download PDF

14. Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: results of a self-reporting questionnaire.

Author

Vagts C, Sweis JJG, Sweis NWG, Ascoli C, Rottoli P, Martone FM, Wells AU, Judson MA, Sweiss NJ, Lower EE, and Baughman RP

Abstract

Background: Individuals with self-declared sarcoidosis are at increased risk of COVID-19 related morbidity and mortality for which vaccination can be lifesaving. Despite this, vaccine hesitancy remains a large barrier to global acceptance of vaccination against COVID-19. We aimed to identify individuals with sarcoidosis who had and had not been vaccinated against COVID-19 vaccine to 1) establish a safety profile of COVID-19 vaccination in those with sarcoidosis and 2) to elucidate factors that contribute to COVID-19 vaccine hesitancy., Methods: A questionnaire inquiring about COVID-19 vaccination status, vaccination side effects, and willingness for future vaccination was distributed from December 2020 to May 2021 to individuals with sarcoidosis living in the US and European countries. Details regarding sarcoidosis manifestations and treatment were solicited. Vaccine attitudes were classified as pro or anti-COVID-19 vaccination for subgroup analysis., Results: At the time of questionnaire administration, 42% of respondents had already received a COVID-19 vaccination, most of whom either denied side effects or reported a local reaction only. Those off sarcoidosis therapy were more likely to report systemic side effects. Among subjects who had not yet received a COVID-19 vaccine, 27% of individuals reported they would not receive one once available. Reasons against vaccination were overwhelmingly related to the lack of confidence in vaccine safety and/or efficacy and less related to concerns associated with convenience or complacency. Black individuals, women, and younger adults were more likely to decline vaccination., Conclusions: Among individuals with sarcoidosis, COVID-19 vaccination is well-accepted and well-tolerated. Subjects on sarcoidosis therapy reported significantly less vaccination side effects, and thus the correlation between side effects, vaccine type, and vaccine efficacy requires further investigation. Strategies to improve vaccination should focus on improving knowledge and education regarding vaccine safety and efficacy, as well as targeting sources of misinformation, particularly in young, black, and female subpopulations.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results